aica ribonucleotide has been researched along with Cachexia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedard, N; Di Marco, S; Ford, RJ; Gallouzi, IE; Griss, T; Hall, DT; Jones, RG; Ma, JF; Mubaid, S; Omer, A; Pause, A; Sadek, J; Sanchez, BJ; Steinberg, GR; Tremblay, AMK; Wing, SS | 1 |
| Adamo, S; Aulino, P; Barone, R; Berardi, E; Carraro, U; Coletti, D; Di Felice, V; Gruppo, M; Kern, H; Li, Z; Macaluso, F; Mericskay, M; Merigliano, S; Moresi, V; Pigna, E; Rizzuto, E; Rocchi, M; Zampieri, S | 1 |
2 other study(ies) available for aica ribonucleotide and Cachexia
| Article | Year |
|---|---|
The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Animals; Cachexia; Cell Line; Enzyme Activation; Inflammation; Interferon-gamma; Male; Metformin; Mice, Inbred BALB C; Mitochondria; Muscle, Skeletal; Neoplasms, Experimental; Nitric Oxide Synthase Type II; Protein Kinases; Ribonucleotides; Shock, Septic; Tumor Necrosis Factor-alpha | 2018 |
Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer.
Topics: Aminoimidazole Carboxamide; Animals; Autophagosomes; Autophagy; Cachexia; Cell Line, Tumor; Colonic Neoplasms; Female; Humans; Lysosomes; Mice; Mice, Inbred BALB C; Muscle Fibers, Skeletal; Muscle Weakness; Muscle, Skeletal; Neoplasm Transplantation; Physical Conditioning, Animal; Ribonucleotides; Sirolimus; Survival Analysis | 2016 |